Cargando…

Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II

Both the activation of the renin angiotensin aldosterone system (RAAS) and elevations of circulating Fibroblast Growth Factor-23 (FGF-23) have been implicated in the pathogenesis of left ventricular hypertrophy (LVH) in chronic kidney disease. To investigate potential cross-talk between RAAS and FGF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pi, Min, Ye, Ruisong, Han, Xiaobin, Armstrong, Benjamin, Liu, Xue, Chen, Yuanjian, Sun, Yao, Quarles, L. Darryl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098163/ https://www.ncbi.nlm.nih.gov/pubmed/30120363 http://dx.doi.org/10.1038/s41598-018-30098-1

Ejemplares similares

Role of Fibroblast Growth Factor-23 in Innate Immune Responses
por: Fitzpatrick, Elizabeth A., et al.
Publicado: (2018)

The hypoxia-inducible factor-1α activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia
por: Zhang, Qian, et al.
Publicado: (2016)

CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model
por: Ye, Ruisong, et al.
Publicado: (2017)

Role of GPRC6A in Regulating Hepatic Energy Metabolism in Mice
por: Pi, Min, et al.
Publicado: (2020)

Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23
por: Xiao, Zhousheng, et al.
Publicado: (2014)

Computationally identified novel agonists for GPRC6A
por: Pi, Min, et al.
Publicado: (2018)

Humanized GPRC6A(KGKY) is a gain-of-function polymorphism in mice
por: Pi, Min, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Cardiovascular Risk in Diabetes Patients—Cardiologists Be Aware
por: Kurpas, Anna, et al.
Publicado: (2022)

Intracellular Angiotensin‐II Interacts With Nuclear Angiotensin Receptors in Cardiac Fibroblasts and Regulates RNA Synthesis, Cell Proliferation, and Collagen Secretion
por: Tadevosyan, Artavazd, et al.
Publicado: (2017)

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomization study
por: Donovan, Killian, et al.
Publicado: (2023)

Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle‐Aged Adults
por: Paul, Shejuti, et al.
Publicado: (2021)

Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?
por: Kizilgul, Muhammed, et al.
Publicado: (2017)

GPRC6A: Jack of all metabolism (or master of none)
por: Pi, Min, et al.
Publicado: (2016)

Explaining Divergent Observations Regarding Osteocalcin/GPRC6A Endocrine Signaling
por: Pi, Min, et al.
Publicado: (2021)

Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study
por: Haring, Robin, et al.
Publicado: (2016)

Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease
por: Ding, Hong-Ying, et al.
Publicado: (2015)

Genome-wide association study for circulating fibroblast growth factor 21 and 23
por: Chuang, Gwo-Tsann, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism
por: Saito, Tasuku, et al.
Publicado: (2009)

PKC regulates the production of fibroblast growth factor 23 (FGF23)
por: Bär, Ludmilla, et al.
Publicado: (2019)

The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
por: Heijboer, Annemieke C., et al.
Publicado: (2022)

Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Linkage of Fibroblast Growth Factor 23 and Phosphate in Serum: Phosphate and Fibroblast Growth Factor 23 Reduction by Increasing Dose of Sevelamer
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2018)

Metformin Inhibits Angiotensin II-Induced Differentiation of Cardiac Fibroblasts into Myofibroblasts
por: Bai, Jian, et al.
Publicado: (2013)

A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway
por: Wang, Joseph, et al.
Publicado: (2017)

Circulating Fibroblast Growth Factor-23 is Associated with Cardiovascular Prognosis and Graft Function in Renal Transplant Recipients
por: Algul Durak, Beyza, et al.
Publicado: (2020)

Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
por: Feger, Martina, et al.
Publicado: (2021)

Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer
por: Ewendt, Franz, et al.
Publicado: (2021)

Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension
por: Lin, Yao, et al.
Publicado: (2019)

Fibroblast Growth Factor–23 and Cardiac Structure and Function
por: Agarwal, Isha, et al.
Publicado: (2014)

The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
por: Czaya, Brian, et al.
Publicado: (2019)

Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
por: Brito Galvao, Joao F, et al.
Publicado: (2013)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease
por: Hu, Peng, et al.
Publicado: (2012)

Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery
por: Hofer, Felix, et al.
Publicado: (2023)

Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function
por: Kee, Youn Kyung, et al.
Publicado: (2023)

FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function
por: Laszczyk, Ann M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ftke8oip9u4017nrv94jclt4dp